StockData

Can B Corp (NASC) stock

NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)

Close on Oct 19, 2026Market cap $981.54KP/E –Yield –

Can B r&d expenses

Research and development expenses are spending on new products and technology.

Can B's R&D Expenses for the twelve months ending Dec 31, 2020 was $165.00K, up 10.0% year over year. For fiscal 2020 it was $165.00K, up 10.0% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2020Dec 31, 2020$165.00K+10.0%
FY2019Dec 31, 2019$150.00K+100.0%
FY2018Dec 31, 2018$75.00K+102.7%
FY2017Dec 31, 2017$37.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$85.00K-19.0%
Q3 FY2020Sep 30, 2020$55.00K+57.1%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$25.00K+42.9%
Q4 FY2019Dec 31, 2019$105.00K+68.0%
Q3 FY2019Sep 30, 2019$35.00K–
Q2 FY2019Jun 30, 2019$52.50K+425.0%
Q1 FY2019Mar 31, 2019$17.50K+600.0%
Q4 FY2018Dec 31, 2018$62.50K–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$10.00K–
Q1 FY2018Mar 31, 2018$2.50K–

More Can B figures

See a number that looks wrong?